Magpale, Nicasio R.

HRN: 22-61-27  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/03/2025
12/10/2025
IV
2.25g
Q8h
Non Healing Wound Left Foot
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines